Jump to content

Magnesium pidolate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 11:11, 3 December 2010 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:Wi). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Magnesium pidolate
Clinical data
ATC code
Identifiers
  • Magnesium 5-oxopyrrolidine-2-carboxylate
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.080.955 Edit this at Wikidata
Chemical and physical data
FormulaC10H12N2MgO6
3D model (JSmol)
  • [Mg+2].[O-]C(=O)C1NC(=O)CC1.[O-]C(=O)C1NC(=O)CC1
  • InChI=1S/2C5H7NO3.Mg/c2*7-4-2-1-3(6-4)5(8)9;/h2*3H,1-2H2,(H,6,7)(H,8,9);/q;;+2/p-2 checkY
  • Key:JQAACYUZYRBHGG-UHFFFAOYSA-L checkY
  (verify)

Magnesium pidolate, the magnesium salt of pidolic acid (pyroglutamic acid), is a mineral supplement.

  • De Franceschi L, Bachir D, Galacteros F; et al. (2000). "Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease". Br. J. Haematol. 108 (2): 284–9. doi:10.1046/j.1365-2141.2000.01861.x. PMID 10691856. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)